Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125480051 | 12548005 | 1 | I | 20160527 | 0 | 20160711 | 20160711 | DIR | 75.00 | YR | F | N | 170.00000 | LBS | 20160709 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125480051 | 12548005 | 1 | PS | SAVELLA | MILNACIPRAN HYDROCHLORIDE | 1 | Oral | 60 TABLET(S) ONCE A DAY TAKEN BY MOUTH | N | D | 20170524 | 0 | 60 | DF | COATED TABLET | QD | |||
| 125480051 | 12548005 | 3 | C | NORDITROPIN (HGH) | 2 | 0 | |||||||||||||
| 125480051 | 12548005 | 5 | C | EVISTA | RALOXIFENE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 7 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 9 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 11 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 13 | C | CPAP | DEVICE | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 15 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 17 | C | HYALURONIC ACID | HYALURONIC ACID | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 19 | C | ZINC | ZINCINC CHLORIDE | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 21 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 23 | C | CALCIUM SUPPLEMENTS | CALCIUM | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 25 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 27 | C | OSTEO-BIFLEX | 2 | 0 | |||||||||||||
| 125480051 | 12548005 | 29 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 31 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 33 | C | RIBOSE | DIETARY SUPPLEMENT | 1 | 0 | ||||||||||||
| 125480051 | 12548005 | 35 | C | PHILLIPS FIBER | 2 | 0 | |||||||||||||
| 125480051 | 12548005 | 37 | C | SCHIFF DIGESTIVE ADVANTAGE | 2 | 0 | |||||||||||||
| 125480051 | 12548005 | 39 | C | MAGNESIUM MALATE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125480051 | 12548005 | 1 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125480051 | 12548005 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125480051 | 12548005 | Blood pressure increased | |
| 125480051 | 12548005 | Confusional state | |
| 125480051 | 12548005 | Constipation | |
| 125480051 | 12548005 | Coordination abnormal | |
| 125480051 | 12548005 | Delirium | |
| 125480051 | 12548005 | Dizziness | |
| 125480051 | 12548005 | Drug effect decreased | |
| 125480051 | 12548005 | Fatigue | |
| 125480051 | 12548005 | Hyperhidrosis | |
| 125480051 | 12548005 | Nausea | |
| 125480051 | 12548005 | Presyncope | |
| 125480051 | 12548005 | Therapy change | |
| 125480051 | 12548005 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125480051 | 12548005 | 1 | 20160527 | 20160613 | 0 |